Acutus Medical
Logotype for Acutus Medical Inc

Acutus Medical (AFIB) investor relations material

Acutus Medical has been otc

Acutus Medical Q4 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Acutus Medical Inc
Q4 2024 earnings summary24 Mar, 2025

Executive summary

  • 2024 revenue from continuing operations reached $20.2 million, up 181% year-over-year from $7.2 million.

  • Operating loss for continuing operations narrowed to $0.1 million from $11.7 million last year.

  • Net loss from continuing operations was $4.6 million, with net loss per share at $0.16, compared to $11.9 million and $0.40 per share last year.

  • Loss on discontinued operations was $5.0 million, a significant improvement from $69.7 million last year.

  • Company realigned focus to left-heart access products and exited electrophysiology mapping and ablation businesses.

Financial highlights

  • Gross margin for continuing operations improved to 5% from negative 44% year-over-year, driven by higher production volumes and reduced overhead.

  • Operating expenses for continuing operations dropped to $1.1 million from $8.6 million, reflecting reduced discretionary spend.

  • Cash, cash equivalents, marketable securities, and restricted cash totaled $14.0 million as of December 31, 2024.

  • Gain on sale of business was $10.8 million, up 19% year-over-year.

Outlook and guidance

  • No further financial guidance will be provided due to the business realignment and exit from certain business lines.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Acutus Medical
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Acutus Medical, Inc. is a medical device company focused on developing technologies for the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. The company offers a range of products, including mapping and imaging systems designed to provide real-time, high-resolution data to guide electrophysiologists during cardiac ablation procedures. The company is headquartered in Carlsbad, United States, and its shares are listed on the NASDAQ.